http://www.fpnotebook.com/
Chronic Narcotic Guideline
Aka: Chronic Narcotic Guideline, Chronic Narcotic, Chronic Opioid
- See Also
- Chronic Pain
- Chronic Pain Management
- Somatization
- DIRE Score
- Opioid Risk Tool
- Contraindications (Relative for Chronic Pain)
- Substance Abuse (especially Narcotic Abuse)
- Severe character pathology or Personality Disorder
- Chaotic social environment
- Guidelines: Chronic Opioid Use Guidelines in Non-Cancer Chronic Pain
- Observe for Narcotic Seeking Behavior
- Avoid confusing Pseudo-addiction for addiction
- Avoid inadequate treatment of pain
- Single clinician should primarily manage patient
- Incorporate Narcotic contract consistently
- Maintain Narcotic use flow sheet
- Titrate to pain relief and adverse effects
- Reevaluate on a 1-4 week basis
- Documentation is key (see follow-up below)
- Convert short-acting Narcotics to long-acting Narcotics
- Use long-acting Narcotics around the clock
- Use short-acting Narcotics for breakthrough pain
- Use in combination with other therapy
- See Chronic Pain Management
- Non-Opioid Analgesics
- Make use of non-pharmacologic modalities
- Treat Narcotic adverse effects prophylactically
- See Bowel Regimen in Chronic Narcotic Use
- Be aware of pseudotolerance
- Opioid appears to fail to control pain
- Pain flares are countered with escalated dosing and not returning to prior baseline
- Set expectations with patient
- Medication returns to prior baseline after brief flare
- Unauthorized dosage increases are not allowed
- Protocol: Initial Assessment for non-Cancer Pain Chronic Narcotic therapy
- Select appropriate patients for Chronic Opioids
- See DIRE Score
- Complete prerequisites at initial visit
- Controlled Medication Agreement (Narcotic Contract)
- Urine Drug Screen
- Educate regarding expectations
- Review pain control expectations
- Expect a 20% pain reduction at best
- See Chronic Pain Management
- Review escalating and tapering the dose
- Review rules and protocol when non-compliant
- Review Chronic Pain Flare Management
- Flares are same pain type and same location with an increase in intensity
- Protocol: Follow-up Visits
- Schedule follow-ups
- Initial: Reevaluate on a 1-4 week basis
- Later: Reevaluate every 3 months
- Documentation: 4A's
- Analgesia
- Document pain level (scale of 1 to 10)
- Adverse Effects
- Document Opioid side effects (e.g. Constipation, Nausea or Vomiting, Sedation)
- Activity Level
- Document functional status
- Following regular Exercise?
- See Exercise in Chronic Pain
- Adherence
- Annually renew Controlled Medication Agreement (Narcotic Contract)
- Document compliance with prescribed therapy (see pill counts below)
- Last physical therapy visit
- Last mental health provider visit
- Documentation: Comorbidity
- Major Depression (consider PHQ-9)
- Anxiety Disorder (consider GAD-7)
- Sleep disorders
- Pregnancy
- Monitoring
- Urine Drug Screen
- Pill Counts
- Patient should bring pill bottles to each visit
- Reassess DIRE Score
- Indications to stop Opioid therapy
- DIRE Score falls below 14
- Marginal pain control or decreasing function
- Non-compliance with prescriptions or with self-care
- Protocol: Stopping Chronic Narcotics
- See Opioid Withdrawal
- References
- Sokolove (2001) CMEA Medicine Lecture, San Diego